Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis

ASLAN Pharmaceuticals · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
atopic-dermatitis
atopic dermatitis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 839173
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.